rituximab 100 mg / 10 mL (10 mL INJECTION)
|
$107.5200
|
|
VA NC
|
|
|
rituximab 100 mg / 10 mL (10 mL INJECTION)
|
$150.7455
|
|
AUS PBS
|
generic
|
Riximyo (2) |
Sandoz Pty Ltd |
Truxima (2) |
Celltrion Healthcare Australia Pty Ltd |
Mabthera (2) |
Roche Products Pty Ltd |
|
rituximab 100 mg / 10 mL (10 mL INJECTION)
|
$483.0100
|
|
VA Big4
|
|
Ruxience (1) |
Pfizer, Inc. |
|
rituximab 100 mg / 10 mL (10 mL INJECTION)
|
$543.6700
|
|
VA Big4
|
|
Riabni (1) |
Amgen USA, Inc. |
|
rituximab 100 mg / 10 mL (10 mL INJECTION)
|
$612.3400
|
|
VA FSS
|
|
Ruxience (1) |
Pfizer, Inc. |
|
rituximab 100 mg / 10 mL (10 mL INJECTION)
|
$684.3800
|
|
VA FSS
|
|
Riabni (1) |
Amgen USA, Inc. |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$49.1590
|
|
VA Big4
|
|
Truxima (10) |
Teva Pharmaceuticals USA, Inc. |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$49.3792
|
|
VA Big4
|
|
Truxima (50) |
Teva Pharmaceuticals USA, Inc. |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$61.1856
|
|
VA FSS
|
|
Truxima (50) |
Teva Pharmaceuticals USA, Inc. |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$61.1860
|
|
VA FSS
|
|
Truxima (10) |
Teva Pharmaceuticals USA, Inc. |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$66.1278
|
|
VA Big4
|
|
Rituxan (50) |
Genentech USA |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$66.1640
|
|
VA Big4
|
|
Rituxan (10) |
Genentech USA |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$89.8840
|
|
VA FSS
|
|
Rituxan (10) |
Genentech USA |
Rituxan (50) |
Genentech USA |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$661.5060
|
|
VA Big4
|
|
Rituxan (10) |
Genentech USA |
|
rituximab 10 mg / 1 mL (1 mL INJECTION)
|
$939.5200
|
|
VA FSS
|
|
Rituxan (10) |
Genentech USA |
|
rituximab 1.4 g / 11.7 mL (INJECTION)
|
$1359.3025
|
|
AUS PBS
|
generic
|
Mabthera SC (1) |
Roche Products Pty Ltd |
|
rituximab 500 mg / 50 mL (50 mL INJECTION)
|
$537.6000
|
|
VA NC
|
|
|
rituximab 500 mg / 50 mL (50 mL INJECTION)
|
$753.7234
|
|
AUS PBS
|
generic
|
Riximyo (1) |
Sandoz Pty Ltd |
Truxima (1) |
Celltrion Healthcare Australia Pty Ltd |
Mabthera (1) |
Roche Products Pty Ltd |
|
rituximab 500 mg / 50 mL (50 mL INJECTION)
|
$2430.0900
|
|
VA Big4
|
|
Ruxience (1) |
Pfizer, Inc. |
|
rituximab 500 mg / 50 mL (50 mL INJECTION)
|
$2717.8400
|
|
VA Big4
|
|
Riabni (1) |
Amgen USA, Inc. |
|
rituximab 500 mg / 50 mL (50 mL INJECTION)
|
$3061.7100
|
|
VA FSS
|
|
Ruxience (1) |
Pfizer, Inc. |
|
rituximab 500 mg / 50 mL (50 mL INJECTION)
|
$3421.9100
|
|
VA FSS
|
|
Riabni (1) |
Amgen USA, Inc. |
|